In addition, the eligibility criteria can vary depending on regulatory guidelines and the individual assessments of healthcare providers
Gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation affect 3050% of patients during the first weeks
Its weight loss application was later studied and approved under the brand name Wegovy at a higher dose
Eligibility: The minimum BMI for new patients is 25
Signs of degradation include cloudiness, particulate matter floating in the solution, or significant color changes
The study medicines will be in a pen, and must be injected with a needle in the thigh A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes Intervention 1 Intervention 2 Not provided Anticipated Start Date Not provided Actual Start Date 2019-05-07 Anticipated Date of Last Follow-up 2023-09-01 Estimated Primary Completion Date Not provided Estimated Completion Date Not provided Actual Primary Completion Date 2021-09-27 Actual Completion Date 2021-09-27 Age Cohort Genders Accepts pregnant individuals Unspecified Accepts lactating individuals Unspecified Accepts healthy individuals No Inclusion Criteria: * Male or female, aged between 18 and 72 years (both inclusive) at the time of signing informed consent
